[We must respect the anti-SARS-CoV-2 vaccine schedule without delay in cancer patients under treatment]
- PMID: 33741139
- PMCID: PMC7934697
- DOI: 10.1016/j.bulcan.2021.02.003
[We must respect the anti-SARS-CoV-2 vaccine schedule without delay in cancer patients under treatment]
References
-
- Meerveld-Eggink A., de Weerdt O., van der Velden A.M.T., Los M., van der Velden A.W.G., Stouthard J.M.L. Response to influenza virus vaccination during chemotherapy in patients with breast cancer. Ann Oncol. 2011;22(9):2031–2035. doi: 10.1093/annonc/mdq728. [Epub 2011 Feb 8; PMID: 21303799] - DOI - PubMed
-
- Rousseau B., Loulergue P., Mir O., Krivine A., Kotti S., Viel E. Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study. Ann Oncol. 2012;23(2):450–457. doi: 10.1093/annonc/mdr141. [Epub 2011 May 16; PMID: 21576285] - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous